Company Profile For AstraZeneca PLC

AstraZeneca PLC (AZN.L) (London Stock Exchange)

sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·

As of 23 Nov 2009

2,732.00GBp

Price Change

+37.00

Percent Change

+1.37%

Analyst Recommendations

Overview

AstraZeneca PLC is a United Kingdom-based pharmaceutical company, which discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for areas of healthcare, such as cardiovascular, gastrointestinal, infection, neuroscience, oncology, respiratory and inflammation. Its product range includes Arimidex, Crestor, Nexium, Seroquel and Symbicort. The Company has 26 manufacturing sites in 18 countries. On October 10, 2007, the Company’s subsidiary, Astra Tech, acquired Atlantis Components Inc. Astra Tech is engaged in the research, development, manufacture and marketing of medical devices and implants for use in healthcare, primarily in urology, surgery and odontology.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, AstraZeneca plc's revenues increased 2% to $23.86B. Net income increased 23% to $5.98B. Revenues reflect a higher income from US, Japan and China. Net income also reflects a decrease in research & development expenses, lower distribution costs, a decrease in selling, general & administrative costs, increased operating profit margin and lower finance expense.